In pancreatic cancer (PC), ALKBH5-mediated m6A modification caused DDIT4-AS1 overexpression, and DDIT-AS1 increased cancer stemness and led to gemcitabine resistance by destabilizing DDIT4 and activating the mTOR pathway [156]. This evidence concerns the gene DDIT4 and pancreatic neoplasm.